Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells

Virus Research

Volumn 66, Issue 1, 2000, Pages 51-63

  Ikeda, Masanori ^a,b   Nozaki, Akito ^a   Sugiyama, Kazuo ^a   Tanaka, Torahiko ^a   Naganuma, Atsushi ^a   Tanaka, Katsuaki ^b   Sekihara, Hisahiko ^b   Shimotohno, Kunitada ^c   Saito, Masaki ^a   Kato, Nobuyuki ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c Lab Hum Tum Viruses Inst V   (Japan)

Author keywords

Bovine lactoferrin; Hepatitis C virus; Hepatitis G virus; MT 2C cells; PH5CH8 cells

Indexed keywords

BETA LACTOGLOBULIN; CASEIN; GLYCOPROTEIN; LACTOFERRIN; MILK PROTEIN; MUCIN;

ANTIBACTERIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; HEATING; HEPATITIS C; HEPATITIS G VIRUS; HUMAN; HUMAN CELL; IRON TRANSPORT; LIVER CELL; LYMPHOCYTE; PRIORITY JOURNAL; VIRUS NEUTRALIZATION;

ANIMALS; ANTIVIRAL AGENTS; CATTLE; CELL LINE; CELL LINE, TRANSFORMED; FLAVIVIRIDAE; HEAT; HEPACIVIRUS; HUMANS; LACTOFERRIN; LIVER; RNA, VIRAL; T-LYMPHOCYTES;

EID: 0033956354     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(99)00121-5     Document Type: Article

References (40)

1. Bellamy W., Takase M., Yamauchi K., Wakabayashi H., Kawase K., Tomita M. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta. 1121:1992;130-136.
2. Brock J. Lactoferrin: a multifunctional immunoregulatory protein. Immunol. Today. 16:1995;417-419.
3. Bukh J., Miller R.H., Purcell R.H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin. Liver Dis. 15:1995;41-63.
4. Choo Q.-L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-born non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
5. Ellison III R.T., Giehl T.J., Laforce F.M. Damage of the outer membrane of the enteric Gram-negative bacteria by lactoferrin and transferrin. Infect. Immun. 56:1988;2774-2781.
6. Ferri C., Monti M., Civita L.L., Longombardo G., Greco F., Pasero G., Gentilini P. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood. 82:1993;3701-3704.
7. Harmsen M.C., Swart P.J., De Bethune M.-P., Pauwels R., De Clercq E., The T.H., Meijer D.K.F. Antiviral effects of plasma milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J. Infect. Dis. 172:1995;380-388.
8. Hasegawa K., Motsuxhi W., Tanaka S., Dosako S. Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn. J. Med. Sci. Biol. 47:1994;73-85.
9. Hutchens T.W., Henry J.F., Yip T.T. Structurally intact (78-kDa) forms of maternal lactoferrin purified from urine of preterm infants fed human milk; identification of a trypsin-like proteolytic cleavage event in vivo that does not result in fragment dissociation. Proc. Natl. Acad. Sci. USA. 88:1991;2994-2998.
10. Ikeda M., Kato N., Mizutani T., Sugiyama K., Tanaka K., Shimotohno K. Analysis of cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes. J. Hepatol. 27:1997;445-454.
11. Ikeda M., Sugiyama K., Mizutani T., Tanaka T., Tanaka K., Shimotohno K., Kato N. Hepatitis G virus replication in human cultured cells displaying susceptibility to hepatitis C virus. Biochem. Biophys. Res. Commun. 235:1997;505-508.
12. Ikeda M., Sugiyama K., Mizutani T., Tanaka T., Tanaka K., Sekihara H., Shimotohno K., Kato N. Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus. Virus Res. 56:1998;157-167.
13. Ikeda M., Sugiyama K., Tanaka T., Tanaka K., Sekihara H., Shimotohno K., Kato N. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Biochem. Biophys. Res. Commun. 245:1998;549-553.
14. Kajikawa M., Ohta T., Takase M., Kawase K., Shimamura S., Matsuda I. Lactoferrin inhibits cholesterol accumulation in macrophages mediated by acetylated or oxidized low-density lipoproteins. Biochim. Biophys. Acta. 1213:1994;82-90.
15. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. USA. 87:1990;9524-9528.
16. Kato N., Sekiya H., Ootsuyama Y., Nakazawa T., Hijikata M., Ohkoshi S., Shimotohno K. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J. Virol. 67:1993;3923-3930.
17. Kato N., Ikeda M., Mizutani T., Sugiyama K., Noguchi M., Hirohashi S., Shimotohno K. Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes. Jpn. J. Cancer Res. 87:1996;787-792.
18. Koff R.S. Problem hepatitis virus: the mutants. Am. J. Med. 96(Suppl 1A):1994;52S-56S.
19. Kuo G., Choo Q.-L., Alter H.J., Gitnick G.L., Redwker A.G., Purcell R.H., Miyamura T., Dienstag J.L., Alter M.J., Stevens C.E., Tegtmeier G.E., Bonino F., Colombo W.S., Lee W.S., Kuo C., Berger K., Shuster J.R., Overby L.R., Bradley D.W., Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 244:1989;362-364.
20. Leary T.P., Muerhoff A.S., Simons J.N., Pilot-Matias T.L., Erker J.C., Chalmers M.L., Schlauder G.G., Dawson G.J., Desai S.M., Mashahwar A.K. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J. Med. Virol. 48:1996;60-67.
21. Levay P.F., Viljoen M. Lactoferrin: a general review. Haematologica. 80:1995;252-267.
22. McHutchison J.G., Gordon S.C., Schiff E.R., Shiffman M.L., Lee W.M., Rustgi V.K., Goodman Z.D., Ling M.H., Cort S., Albrecht J.K. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N. Engl. J. Med. 339:1998;1485-1492.
23. Mizutani T., Kato N., Saito S., Ikeda M., Sugiyama K., Shimotohno K. Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2. J. Virol. 70:1996;7219-7223.
24. Mizutani T., Kato N., Ikeda M., Sugiyama K., Shimotohno K. Long-term human T cell culture system supporting hepatitis C virus replication. Biochem. Biophys. Res. Commun. 277:1996;822-826.
25. Mizutani T., Ikeda M., Saito S., Sugiyama K., Shimotohno K., Kato N. Single-step reverse transcription-polymerase chain reaction for the detection of hepatitis C virus RNA. Microbiol. Immunol. 42:1998;544-553.
26. Noguchi M., Hirohashi S. Cell lines from non-neoplastic liver and hepatocellular carcinoma tissue from a single patient. In Vitro Cell. Dev. Biol. Anim. 32:1996;135-137.
27. Ohkoshi S., Kojima H., Tawaraya H., Miyajima T., Kamimura T., Asakura H., Satoh A., Hirose S., Hijikata M., Kato N., Shimotohno K. Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma. Jpn. J. Cancer Res. 81:1990;550-552.
28. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., Weiner A.J., Houghton M., Rosa D., Grandi G., Abrignani S. Binding of hepatitis C virus to CD81. Science. 282:1998;938-941.
29. Purcell R. The hepatitis C virus: overview. Hepatology. 26(Suppl 1):1997;11S-14S.
30. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Ohya Y., Choo Q.-L., Houghton M., Kuo G. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA. 87:1990;6547-6549.
31. Sanchez L., Aranda P., Perez M.D., Calvo M. Concentration of lactoferrin and transferrin throughout lactation in cow's colostrum and milk. Biol. Chem. Hoppe-Seyler. 369:1988;1005-1008.
32. Sekine K., Watanabe E., Nakamura J., Takasuka N., Kim D.J., Asamoto M., Krutovskikh V., Baba-Toruyama H., Ota T., Moore M.A., Masuda M., Sugimoto H., Nishino H., Kakizoe T., Tsuda H. Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats. Jpn. J. Cancer Res. 88:1997;523-526.
33. Shiratori Y., Kato N., Yokosuka O., Imazeki F., Hashimoto E., Hayashi N., Nakamura A., Asada M., Kuroda H., Tanaka N., Arakawa Y., Omata M. Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba hepatitis research group. Gastroenterology. 113:1997;558-566.
34. Silvestri F., Pipan C., Barillari G., Zaja F., Fanin R., Infanti L., Russo D., Falasca E., Botta G.A., Baccarani M. Prevalence of hepatitis C virus infection in patient with lymphoproliferative disorder. Blood. 87:1996;4296-4301.
35. Superti F., Ammendolia M.G., Valent P., Seganti L. Antirotaviral activity of milk protein: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Med. Microbiol. Immunol. 186:1997;83-91.
36. Tanaka T., Kato N., Cho M.J., Shimotohno K. A novel sequence found at the 3′ terminus of hepatitis C virus genome. Biochem. Biophys. Res. Commun. 215:1995;744-749.
37. Tanaka K., Ikeda M., Nozaki A., Kato N., Tsuda H., Saito S., Sekihara H. Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study. Jpn. J. Cancer Res. 90:1999;367-371.
38. van Dijk M.C., Ziere G.J., van Berkel T.J. Characterization of the chylomicron-remnant-recognition sites on parenchymal and Kupffer cells of rat liver. Selective inhibition of parenchymal cell recognition by lactoferrin. Eur. J. Biochem. 205:1992;775-784.
39. Yi M., Keneko S., Yu D.Y., Murakami S. Hepatitis C virus envelope proteins bind lactoferrin. J. Virol. 71:1997;5997-6002.
40. Yolken R.H., Peterson J.A., Vonderfecht S.L., Fouts E.T., Midthum K., Newburg D.S. Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J. Clin. Invest. 90:1992;1984-1991.